RecruitingNCT06604884

NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study

Neurovascular Product Surveillance Registry (NV PSR INSPIRE) Pipeline™ Vantage Embolization Device With Shield Technology™ Post Approval Study (PAS)

Sponsor

Medtronic Neurovascular Clinical Affairs

Enrollment

118 participants

Start Date

Dec 12, 2025

Study Type

OBSERVATIONAL

Conditions

Intracranial Aneurysm

Summary

The purpose of the Pipeline™ Vantage Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Vantage PAS") is to collect safety and effectiveness data in patients undergoing treatment for intracranial aneurysms (IA) using the Pipeline™ Vantage Embolization Device with Shield Technology™ ("Pipeline™ Vantage Device") in a post approval setting.

Eligibility

Min Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Treatment of Intracranial Aneurysms for people with intracranial aneurysm. The study is currently recruiting participants at 6 locations. People eligible for this study include aged 22 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.